Thuja Capital

Thuja Capital

A venture capital and private equity firm investing in early-stage medical technology and healthcare companies.

Thuja Capital is a venture capital and private equity firm investing in early-stage medical technology and healthcare companies that is headquartered in Utrecht, Netherlands and was founded in 2006 by Harrold van Barlingen.

Investments

Thuja Capital has made 40 investments, 30 lead investments, and 14 exits. Notable investments made by Thuja Capital include: arGEN-X, Galapagos, Avantium Technologies, Enanta Pharmaceuticals, Nightbalance, Bioceros, Omrix Biopharmacetuicals, Coley Pharmaceutical Group, Vernalis, Intercell, Mellon Medical, Salvia BioElectronics, Encare Biotech, Cytura, Fabulous, and Coley.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
DCPrime

DCPrime is a biotechnology company developing cancer immunotherapies.

A company developing and marketing diagnostic and therapeutic anti-viral products for domesticated animals

Cristal Therapeutics is a Maastricht-based clincial stage pharmaceutical company developing targeted nanomedicines founded in 2011.

5 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.